Table 2.
Patient | Tx Type | Pre-tx Donor/Recipient CMV IgG | Clinical Presentation | Codon in Amino Acid | No. of Induced GRMs/Patient | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
460 I/V | 520 Q | 594 V/G | 595 S/F | 596 G | 603 W | 607 Y/F | |||||
1 | MAC | D-/R+ | CMV colitis, retinitis, and suspected pneumonia | ++a | 2 | ||||||
2 | MAC | D-/R+ | CMV colitis | ++ | 1 | ||||||
3 | MACb | D-/R- | CMV retinitis | ++ | ++ | 2 | |||||
4 | MACb | D-/R+ | CMV colitis | ++ | ++ | 2 | |||||
5 | MAC | D-/R+ | None proven | ++ | 1 | ||||||
6 | NMA | D-/R+ | CMV colitis | ++ | 1 | ||||||
7 | Liver | D+/R- | CMV pneumonia | ++ | ++ | 2 | |||||
8 | Liver | D+/R- | Asymptomatic | ++ | 1 | ||||||
9 | Liver | D+/R- | Asymptomatic | ++ | 1 | ||||||
10 | Lung | D+/R- | CMV pneumonia | ++ | 1 | ||||||
11 | Lung | D+/R- | CMV colitis | ++ | 1 | ||||||
12 | Kidney | D+/R- | Asymptomatic | ++ | ++ | ++ | 3 | ||||
13 | Kidney | D+/R- | Asymptomatic | ++ | 1 | ||||||
14 | Kidney | D+/R- | Asymptomatic | ++ | ++ | ++ | 3 | ||||
15 | Kidney | D+/R- | CMV pneumonia | ++a | ++ | 3 | |||||
16 | Kidney | D+/R- | Asymptomatic | ++ | 1 | ||||||
17 | Kidney | D+/R+ | Asymptomatic | ++ | 1 | ||||||
18 | Kidney | D+/R- | Asymptomatic | ++ | 1 | ||||||
19 | Kidney | D+/R- | Asymptomatic | ++ | 1 | ||||||
No. of patients with mutation | 2/19 | 2/19 | 6/19 | 8/19 | 1/19 | 6/19 | 2/19 | ||||
% with mutation induced | 10.5 | 10.5 | 31.6 | 42.1 | 5.3 | 31.6 | 10.5 |
Patient number corresponds to numbering in Figure 3A.
Abbreviations: CMV, cytomegalovirus; D, donor; GRMs, ganciclovir resistance mutations; HSCT, hematopoietic stem cell transplantation; MAC, myeloablative conditioning regimen; NMA, nonmyeloablative conditioning regimen; R, recipient; SOT, solid organ transplantation; Tx, transplantation; UCB, umbilical cord blood.
aBoth mutation in same codon.
bPediatric patients.